Dupilumab Suppresses Fractional Exhaled Nitric Oxide (FeNO) and Biomarkers of Type 2 Inflammation in Adult Patients with Persistent Uncontrolled Asthma Despite Use of Medium-to-High Dose Inhaled Corticosteroids Plus Long-Acting Beta-Agonists (ICS/LABAs)

Authors:
  • BSBrian N. Swanson
    Brian N. Swanson
  • ATAriel Teper
    Ariel Teper
  • JHJennifer D. Hamilton
    Jennifer D. Hamilton
  • BZBingzhi Zhang
    Bingzhi Zhang
  • HSHeribert Staudinger
    Heribert Staudinger
  • NTNian Tian
    Nian Tian
  • YWYing Wang
    Ying Wang
  • JMJeffrey E. Ming
    Jeffrey E. Ming
  • NGNeil M.H. Graham
    Neil M.H. Graham
  • GPGianluca Pirozzi
    Gianluca Pirozzi

Abstract
No abstract available